Trials / Unknown
UnknownNCT03881501
Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma
A Single Arm, Observational Clinical Trial to Evaluate the Efficacy and Safety of Combination Treatment With Sintilimab Injection Plus Endostar in Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (estimated)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
It is a a single arm, observational clinical trial to evaluate the efficacy and safety of combination treatment with sintilimab injection plus endostar in untreated locally advanced or metastatic hepatocellular carcinoma.
Detailed description
For the first line treatment with untreated locally advanced or metastatic hepatocellular carcinoma, sintilimab injection plus endostar might be one of the treatment choices.
Conditions
Timeline
- Start date
- 2019-03-05
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2019-03-19
- Last updated
- 2019-03-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03881501. Inclusion in this directory is not an endorsement.